UsAgainstAlzheimer’s Action is a relentless advocacy force committed to ending Alzheimer’s disease that presses for greater urgency from government, industry and the scientific community in the drive for effective treatments, prevention and ultimately an Alzheimer’s cure. We accomplish this through leadership and collaborative advocacy.
Since our founding in 2010, UsAgainstAlzheimer’s Action has worked to inform and engage as advocates for change people and organizations across section to accomplish milestone successes, including: Increasing U.S. Government investment in Alzheimer’s research. UsAgainstAlzheimer’s Action played a key role in the 4300 million increase for FY 2021 that was approved by Congress for Alzheimer’s research funding through the National Institutes of Health (NIH). In part because of the work UsAgainstAlzheimer’s Action, annual funding for NIH research increased significantly from yearly averages of $400 million a decade earlier to the $3.1 billion level in FY 2021.